MX9305108A - Capsulas blandas revestidas entericas y metodo para su preparacion. - Google Patents
Capsulas blandas revestidas entericas y metodo para su preparacion.Info
- Publication number
- MX9305108A MX9305108A MX9305108A MX9305108A MX9305108A MX 9305108 A MX9305108 A MX 9305108A MX 9305108 A MX9305108 A MX 9305108A MX 9305108 A MX9305108 A MX 9305108A MX 9305108 A MX9305108 A MX 9305108A
- Authority
- MX
- Mexico
- Prior art keywords
- mixture
- preparation
- soft capsules
- weight
- entericas
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describen cápsulas blandas, revestidas con una capa entérica, que comprenden un copolímero de ácido metacrílico y metil o etil acrilato o metil o etil metacrilato 1:1 y un plastificante, sin necesidad por un subrevestimiento y agregado opcionalmente revestido con una capa protectora, que comprende hidroxiropil metil celulosa o hidroxipropil celulosa o una mezcla de las mismas y un plastificante y método para su preparación.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/935,505 US5330759A (en) | 1992-08-26 | 1992-08-26 | Enteric coated soft capsules and method of preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9305108A true MX9305108A (es) | 1994-02-28 |
Family
ID=25467257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9305108A MX9305108A (es) | 1992-08-26 | 1993-08-23 | Capsulas blandas revestidas entericas y metodo para su preparacion. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5330759A (es) |
EP (1) | EP0587220B1 (es) |
JP (1) | JP3983823B2 (es) |
AT (1) | ATE152618T1 (es) |
AU (1) | AU672982B2 (es) |
CA (1) | CA2101095C (es) |
DE (1) | DE69310461T2 (es) |
DK (1) | DK0587220T3 (es) |
ES (1) | ES2104044T3 (es) |
GR (1) | GR3024351T3 (es) |
HU (1) | HUT64833A (es) |
MX (1) | MX9305108A (es) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US5843479A (en) * | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
US5651983A (en) * | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
US6224911B1 (en) * | 1993-03-16 | 2001-05-01 | Syntex (U.S.A.) Llc | Process for the preparation of enteric coated pharmaceutical dosage forms |
ATE414509T1 (de) * | 1994-07-08 | 2008-12-15 | Astrazeneca Ab | Aus vielen einzeleinheiten zusammengesetzte tablettierte dosisform |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
US5686106A (en) * | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
JP3625940B2 (ja) * | 1996-01-29 | 2005-03-02 | 信越化学工業株式会社 | 水系液のカプセルおよびその製造方法 |
US5919481A (en) * | 1996-06-28 | 1999-07-06 | Ncneil-Ppc, Inc. | Fill material for soft gelatin pharmaceutical dosage form |
US5891474A (en) * | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
US6440448B1 (en) | 1998-03-16 | 2002-08-27 | Joseph Intelisano | Food supplement/herbal composition for health enhancement |
US6139875A (en) * | 1998-09-29 | 2000-10-31 | Eastman Chemical Company | Aqueous enteric coating composition and low gastric permeability enteric coating |
US20070122481A1 (en) * | 1998-11-02 | 2007-05-31 | Elan Corporation Plc | Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer |
US20060240105A1 (en) * | 1998-11-02 | 2006-10-26 | Elan Corporation, Plc | Multiparticulate modified release composition |
JP4613275B2 (ja) * | 1998-11-02 | 2011-01-12 | エラン ファーマ インターナショナル,リミティド | 多粒子改質放出組成物 |
US20090149479A1 (en) * | 1998-11-02 | 2009-06-11 | Elan Pharma International Limited | Dosing regimen |
US20090297597A1 (en) * | 1998-11-02 | 2009-12-03 | Gary Liversidge | Modified Release Ticlopidine Compositions |
GB9824658D0 (en) * | 1998-11-11 | 1999-01-06 | Brown Malcolm D | A capsule based drug delivery system |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
KR20130010512A (ko) | 1999-10-29 | 2013-01-28 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
KR100960200B1 (ko) | 2000-10-30 | 2010-05-27 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
US7842308B2 (en) * | 2001-01-30 | 2010-11-30 | Smithkline Beecham Limited | Pharmaceutical formulation |
DK1545475T3 (da) | 2002-10-01 | 2014-07-28 | Banner Pharmacaps Inc | Enterisk sammensætning til fremstillingen af blød kapselvæg |
US20080220074A1 (en) * | 2002-10-04 | 2008-09-11 | Elan Corporation Plc | Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same |
US20050152969A1 (en) * | 2004-01-08 | 2005-07-14 | Chiprich Timothy B. | Colored liquid-filled soft capsules and method of manufacture thereof |
WO2006063078A2 (en) * | 2004-12-08 | 2006-06-15 | Elan Corporation, Plc | Topiramate pharmaceuticals composition |
US20070298098A1 (en) * | 2005-02-16 | 2007-12-27 | Elan Pharma International Limited | Controlled Release Compositions Comprising Levetiracetam |
MX2007012763A (es) * | 2005-04-12 | 2008-01-14 | Elan Pharma Int Ltd | Composiciones de liberacion controlada que comprenden una cefalosporina para el tratamiento de infeccion bacteriana. |
US20100136106A1 (en) * | 2005-06-08 | 2010-06-03 | Gary Liversidge | Modified Release Famciclovir Compositions |
US20070148248A1 (en) | 2005-12-22 | 2007-06-28 | Banner Pharmacaps, Inc. | Gastric reflux resistant dosage forms |
EP2219621B1 (en) | 2007-11-12 | 2013-12-25 | Pharmaceutics International, Inc. | Tri-molecular complexes and their use in drug delivery systems |
WO2009136493A1 (ja) * | 2008-05-08 | 2009-11-12 | パナソニック株式会社 | 不揮発性記憶素子、及び、不揮発性記憶素子又は不揮発性記憶装置の製造方法 |
US8647645B2 (en) | 2009-05-12 | 2014-02-11 | Bpsi Holdings, Llc | Enhanced moisture barrier immediate release film coating systems and substrates coated therewith |
JP5841526B2 (ja) * | 2009-05-12 | 2016-01-13 | ビーピーエスアイ ホールディングス, エルエルシー | 微粒子径粘着性除去剤を含むフィルムコーティング、及びこれによってコーティングされた基材 |
US8663671B2 (en) | 2009-11-05 | 2014-03-04 | Philip Morris Usa Inc. | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
BR112014024159A2 (pt) | 2012-03-29 | 2017-06-20 | Therabiome Llc | Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice. |
US9907755B2 (en) | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
SI2946774T1 (sl) * | 2014-05-19 | 2020-07-31 | Tillotts Pharma Ag | Obložene kapsule s prirejenim sproščanjem |
CA2950311C (en) | 2014-06-23 | 2019-05-14 | Banner Life Sciences Llc | All natural enteric soft capsules comprising active ingredients |
KR102294577B1 (ko) * | 2015-01-12 | 2021-08-26 | 엔터리스 바이오파마, 인크. | 고체 경구 제형 |
CN104825418B (zh) * | 2015-05-07 | 2018-05-15 | 上海信谊万象药业股份有限公司 | 一种硝苯地平软胶丸及其制备方法 |
CA2997915A1 (en) | 2015-09-15 | 2017-03-23 | C.B. Fleet Company, Incorporated | Bisacodyl compositions and delivery apparatus |
JP7423608B2 (ja) | 2018-09-05 | 2024-01-29 | レナファルマ・アクチボラグ | 鉄含有組成物およびその使用 |
WO2020225395A1 (en) | 2019-05-07 | 2020-11-12 | Bausch Health Ireland Limited | Liquid oral dosage formulations of methylnaltrexone |
EP4142727A1 (en) | 2020-05-02 | 2023-03-08 | Bausch Health Ireland Limited | Methods of reducing mortality risk in subjects suffering from an underlying disease or condition by administration of methylnaltrexone |
EP4169503A1 (en) | 2021-10-20 | 2023-04-26 | Tessenderlo Group NV | Composition comprising gelatin, gelatin films and capsules |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3234331C2 (de) * | 1982-09-16 | 1986-06-05 | A. Nattermann & Cie GmbH, 5000 Köln | Verfahren und Lösungen zum Beschichten von Gelatinekapseln mit magensaftresistenten Überzügen |
US4816259A (en) * | 1987-02-12 | 1989-03-28 | Chase Chemical Company, L.P. | Process for coating gelatin capsules |
EP0313845A1 (en) * | 1987-09-29 | 1989-05-03 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
US5047258A (en) * | 1989-07-14 | 1991-09-10 | Sterling Drug Inc. | Aqueous spray-coating process |
NL9002336A (nl) * | 1990-10-24 | 1992-05-18 | Leuven K U Res & Dev | Bekledings- of matrixmateriaal voor geneesmiddelen. |
-
1992
- 1992-08-26 US US07/935,505 patent/US5330759A/en not_active Expired - Lifetime
-
1993
- 1993-07-22 CA CA002101095A patent/CA2101095C/en not_active Expired - Lifetime
- 1993-08-21 AT AT93202463T patent/ATE152618T1/de active
- 1993-08-21 DK DK93202463.1T patent/DK0587220T3/da active
- 1993-08-21 ES ES93202463T patent/ES2104044T3/es not_active Expired - Lifetime
- 1993-08-21 EP EP93202463A patent/EP0587220B1/en not_active Expired - Lifetime
- 1993-08-21 DE DE69310461T patent/DE69310461T2/de not_active Expired - Lifetime
- 1993-08-23 MX MX9305108A patent/MX9305108A/es unknown
- 1993-08-25 JP JP21029693A patent/JP3983823B2/ja not_active Expired - Fee Related
- 1993-08-25 AU AU44888/93A patent/AU672982B2/en not_active Expired
- 1993-08-26 HU HU9302426A patent/HUT64833A/hu unknown
-
1997
- 1997-08-01 GR GR970401997T patent/GR3024351T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2101095C (en) | 2004-01-20 |
GR3024351T3 (en) | 1997-11-28 |
AU672982B2 (en) | 1996-10-24 |
HUT64833A (en) | 1994-03-28 |
CA2101095A1 (en) | 1994-02-27 |
DE69310461D1 (de) | 1997-06-12 |
DK0587220T3 (da) | 1997-12-01 |
DE69310461T2 (de) | 1997-12-11 |
ES2104044T3 (es) | 1997-10-01 |
US5330759A (en) | 1994-07-19 |
AU4488893A (en) | 1994-03-03 |
EP0587220B1 (en) | 1997-05-07 |
JP3983823B2 (ja) | 2007-09-26 |
EP0587220A1 (en) | 1994-03-16 |
ATE152618T1 (de) | 1997-05-15 |
HU9302426D0 (en) | 1993-11-29 |
JPH06157295A (ja) | 1994-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9305108A (es) | Capsulas blandas revestidas entericas y metodo para su preparacion. | |
AU609916B2 (en) | Sustained release pharmaceutical composition | |
US5834023A (en) | Diltiazem controlled release formulation | |
RU2004121786A (ru) | Лекарственные составы длительного высвобождения, содержащие в качестве активного соединения венлафаксина гидрохлорид | |
RU2011101918A (ru) | Получение лекарственных форм миорелаксантов скелетных мышц с контролируемым высвобождением | |
NO975218D0 (no) | Behandling av inflammatorisk tarmsykdom ved bruk av orale doseringsformer av omega-3-polyumettede syrer | |
KR920702618A (ko) | 약제학적 제형 | |
RU99108461A (ru) | Лекарственная форма для перорального введения с отложенным немедленным высвобождением и способ ее приготовления | |
KR910011243A (ko) | 서방성 약제 용량 단위 | |
EA023971B1 (ru) | Применение композиции, содержащей покрытые энтеросолюбильной оболочкой цистамин или цистеамин, для лечения цистиноза и способ лечения цистиноза | |
BG50712A3 (en) | Method for the production of a pharmaceutical preparation coating with controlled active substance release | |
CO4900024A1 (es) | Composiciones farmaceuticas con revestimiento eterico | |
FI823975A0 (fi) | Farmaceutisk flerenhetssammansaettning | |
JPS57171428A (en) | Preparation of coated solid preparation | |
JPS56127322A (en) | Enteric coating material composition for solid drug | |
KR920019360A (ko) | 담즙산과 그 염을 함유하는 경구용 제어 방출 위 내성 의약 포뮬레이션 | |
KR890006240A (ko) | 조절흡수 딜티아젬 제제 | |
FI821422L (fi) | Foerfarande foer framstaellning av ett nytt farmaceutiskt preparat | |
US6221396B1 (en) | Oral cisapride dosage forms with an extended duration | |
KR900701255A (ko) | 서방성 딜티아젬 제제 | |
RU2006114675A (ru) | Суспензии анальгетиков с контролируемым высвобождением | |
ATE25670T1 (de) | 5-aminosalicylsaeure-o-sulfate von physiologisch unbedenklichen basen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
IL151150A (en) | A multiparticulate form of a drug containing at least two different forms of coated tablets | |
KR940001887A (ko) | 신규 경구제형 | |
KR20000053327A (ko) | 결장내 운반에 사용되는 약학적 제형 |